Revance Therapeutics Inc (NASDAQ:RVNC)

13.02
Delayed Data
As of Sep 22
 +0.55 / +4.41%
Today’s Change
11.10
Today|||52-Week Range
37.98
-29.47%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foley Mark J
Chief Executive Officer
Sale5/15/202370,447$34.55$2.4M-61.58%
Foley Mark J
Chief Executive Officer
Sale3/09/202370,390$31.59$2.2M-57.99%
Foley Mark J
Chief Executive Officer
Sale10/13/202249,274$26.97$1.3M-51.76%
Foley Mark J
Chief Executive Officer
Sale6/09/202331,279$30.72$960.9K-56.44%
Foley Mark J
Chief Executive Officer
Sale8/11/202348,064$18.91$908.9K-31.20%
Schilke Tobin C
Chief Financial Officer
Sale5/15/202321,401$34.55$739.4K-61.58%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale5/15/202321,401$34.55$739.4K-61.58%
Sjuts Dustin S
President
Sale5/15/202321,015$34.55$726.1K-61.58%
Sjuts Dustin S
President
Sale3/09/202321,508$31.59$679.4K-57.99%
Foley Mark J
Chief Executive Officer
Sale7/03/202326,279$24.94$655.4K-48.11%
Page of 6